#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3812	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2088	522.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1683	1683	T	604	T,G	497,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3812	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2088	522.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1417	1417	C	592	C,A	489,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3812	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2088	522.2	0	HET	.	.	.	G642A	.	642	642	G	875	875	G	586	G,A	356,116	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3812	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2088	522.2	0	HET	.	.	.	A69G	.	69	69	A	302	302	A	546	A,G	337,122	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4113	437.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1948	1948	A	482	A,T,G	374,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4113	437.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2582	2582	C	564	C,G	454,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4113	437.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2656	2656	A	565	A,C	445,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4113	437.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3208	3208	C	521	C	418	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	612	folP	852	852	99.88	folP.l15.c4.ctg.1	1952	93.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	941	943	AAA	124;124;122	A;A;A	104;103;103	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	612	folP	852	852	99.88	folP.l15.c4.ctg.1	1952	93.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1172	1174	AGC	125;124;124	A;G;C	103;104;103	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	283	1222	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3931	92.6	1	SNP	p	S91F	0	.	.	271	273	TCC	900	902	TCC	113;115;115	T,C;C;C	86,1;94;90	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	283	1222	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3931	92.6	1	SNP	p	D95N	0	.	.	283	285	GAC	912	914	GAC	114;114;114	G;A;C	91;87;91	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	283	1222	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3931	92.6	1	SNP	p	D95G	0	.	.	283	285	GAC	912	914	GAC	114;114;114	G;A;C	91;87;91	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	502	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1437	102.8	1	SNP	p	G45D	0	.	.	133	135	GGC	505	507	GGC	149;149;149	G;G;C	117;119;118	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	276	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1294	63.7	0	.	n	.	0	A197.	DEL	197	197	A	761	761	A	119	A	99	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1254	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3028	123.2	1	SNP	p	D86N	0	.	.	256	258	GAC	622	624	GAC	146;146;146	G;A,C,T;C,A	117;113,1,1;119,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1254	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3028	123.2	1	SNP	p	S87R	0	.	.	259	261	AGT	625	627	AGT	146;148;148	A,C;G,T;T	114,1;119,1;113	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1254	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3028	123.2	1	SNP	p	S87W	0	.	.	259	261	AGT	625	627	AGT	146;148;148	A,C;G,T;T	114,1;119,1;113	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1254	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3028	123.2	1	SNP	p	S87I	0	.	.	259	261	AGT	625	627	AGT	146;148;148	A,C;G,T;T	114,1;119,1;113	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1254	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3028	123.2	1	SNP	p	S88P	0	.	.	262	264	TCC	628	630	TCC	147;147;147	T;C;C	116;114;118	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1152	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2810	122.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1552	1554	GGC	140;139;140	G;G;C	115;116;110	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1371	1373	GCA	143;143;143	G;C;A	110;114;113	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1374	1376	ATC	142;142;143	A;T;C,T	113;105;112,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1386	1388	GTG	144;144;145	G;T;G	112;113;115	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1386	1388	GTG	144;144;145	G;T;G	112;113;115	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1890	1892	ACC	95;95;94	A,C;C;C	77,2;77;80	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1944	1946	GCG	96;96;97	G,T;C,G,A;G,A	78,1;71,1,1;75,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1944	1946	GCG	96;96;97	G,T;C,G,A;G,A	78,1;71,1,1;75,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2067	2069	GGC	106;106;107	G,A;G;C,T	83,1;88;85,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2076	2078	GGC	107;108;107	G,C;G;C	85,1;84;87	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	912	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2623	103.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2094	2096	CTG	110;110;109	C;T,G;G	85;85,1;84	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1314	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3536	111.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1818	1820	CCG	79;79;78	C;C;G	63;59;57	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	658	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2205	89.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	778	778	C	88	C,G	73,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	511	513	GAA	180;181;180	G,A;A;A	136,1;137;141	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	799	801	GAT	140;140;139	G;A;T	106;110;106	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	922	924	TCA	131;134;134	T;C;A	102;110;113	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1051	1053	GTC	140;141;143	G;T,A;C	108;115,1;117	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1063	1065	TCT	142;141;141	T;C;T	116;114;115	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1381	1383	GCA	173;174;174	G,T;C;A	128,1;132;128	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	1	SNP	p	G120K	1	.	.	358	360	AAG	757	759	AAG	146;146;146	A;A;G	115;111;115	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	1	SNP	p	A121D	1	.	.	361	363	GAC	760	762	GAC	146;146;147	G;A;C	113;117;119	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	750	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1788	123.2	1	SNP	p	D121N	0	.	.	361	363	GAC	760	762	GAC	146;146;147	G;A;C	113;117;119	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2638	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5274	149.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2219	2221	AAT	136;136;136	A;A,T;T,G	114;112,1;108,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	346	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1256	82.4	1	SNP	p	V57M	1	.	.	169	171	ATG	644	646	ATG	136;136;135	A;T;G	113;114;109	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
